Catalyst Pharmaceuticals Newsroom

Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500 List

Catalyst PharmaceuticalsNov 25 00:00 ET

Insider Sale: Director at $CPRX (CPRX) Sells 72,500 Shares

Quiver QuantitativeNov 21 17:17 ET

Catalyst Pharmaceuticals(CPRX.US) Director Sells US$3.63 Million in Common Stock

Moomoo NewsNov 21 17:16 ET

Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswireNov 19 08:03 ET

Stephens Initiates Catalyst Pharmaceuticals(CPRX.US) With Buy Rating, Announces Target Price $35

Moomoo NewsNov 19 03:36 ET · Ratings

Stephens & Co. Initiates Coverage On Catalyst Pharmaceuticals With Overweight Rating, Announces Price Target of $35

BenzingaNov 18 10:28 ET · Ratings

Catalyst Pharmaceuticals(CPRX.US) Director Sells US$3.1 Million in Common Stock

Moomoo NewsNov 15 17:05 ET

Sentiment Still Eluding Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)

Simply Wall StNov 15 06:09 ET

Catalyst Pharmaceuticals(CPRX.US) Director Sells US$11.51 Million in Common Stock

Moomoo NewsNov 13 17:48 ET

Catalyst Pharmaceuticals' (NASDAQ:CPRX) Earnings May Just Be The Starting Point

Yahoo FinanceNov 13 05:48 ET

Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work

Catalyst PharmaceuticalsNov 13 00:00 ET

Form 144 | Catalyst Pharmaceuticals(CPRX.US) Director Proposes to Sell 4.47 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Nov 12, $Catalyst Pharmaceuticals(CPRX.US)$ Director MCENANY PATRICK J intends to sell 192K shares of its common stock on Nov 12, with a total market value of approximately $4.

Moomoo NewsNov 12 14:19 ET

Form 144 | Catalyst Pharmaceuticals(CPRX.US) Director Proposes to Sell 5.42 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Nov 12, $Catalyst Pharmaceuticals(CPRX.US)$ Director MCENANY PATRICK J intends to sell 230K shares of its common stock on Nov 11, with a total market value of approximately $5.

Moomoo NewsNov 12 11:00 ET

Truist Financial Maintains Catalyst Pharmaceuticals(CPRX.US) With Buy Rating, Announces Target Price $36

Moomoo NewsNov 11 07:34 ET · Ratings

BofA Securities Maintains Catalyst Pharmaceuticals(CPRX.US) With Buy Rating

Moomoo NewsNov 8 10:37 ET · Ratings

Oppenheimer Maintains Catalyst Pharmaceuticals(CPRX.US) With Buy Rating, Maintains Target Price $29

Moomoo NewsNov 8 09:38 ET · Ratings

Catalyst Pharmaceuticals Analyst Ratings

BenzingaNov 8 08:14 ET · Ratings

H.C. Wainwright Maintains Catalyst Pharmaceuticals(CPRX.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsNov 8 07:31 ET · Ratings

Catalyst Pharmaceuticals, Inc. (CPRX) Q3 2024 Earnings Call Transcript Summary

moomoo AINov 7 10:39 ET · Conference Call

Truist Financial Maintains Catalyst Pharmaceuticals(CPRX.US) With Buy Rating

Moomoo NewsNov 7 09:31 ET · Ratings